NCT06469671 2024-06-21ArtInColState Scientific Centre of Coloproctology, Russian FederationPhase NA Not yet recruiting1,000 enrolled
NCT06218888 2024-01-23A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver MetastasesFujian Cancer HospitalPhase 2 Not yet recruiting17 enrolled